Northern Trust Company of Connecticut’s Ironwood Pharmaceuticals IRWD Stock Holding History

Northern Trust Company of Connecticut’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$3.75M	Buy	385,570 +74,718	+24%	+$671K	0.02%	813
2013 Q3	$3.08M	Buy	310,852 +1,451	+0.5%	+$14.2K	0.02%	880
2013 Q2	$2.57M	Buy	+309,401	New	+$3.75M	0.02%	927

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Northern Trust Company of Connecticut's IRWD Position: Q4 2013 in Review

Northern Trust Company of Connecticut increased its Ironwood Pharmaceuticals (IRWD) stake by 24% in Q4 2013, buying an estimated $671K and bringing the position to 385,570 shares worth $3.75M. The position accounts for 0.02% of the portfolio, ranked #813.

Northern Trust Company of Connecticut first reported a position in IRWD in Q2 2013 and has held it in 3 quarters since. 124 funds tracked by Wall St. Rank hold IRWD as of Q4 2013.

Northern Trust Company of Connecticut held 385,570 shares of Ironwood Pharmaceuticals worth $3.75M as of Q4 2013.
Northern Trust Company of Connecticut bought 74,718 Ironwood Pharmaceuticals shares in Q4 2013, an estimated $671K.
Ironwood Pharmaceuticals made up 0.02% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #813 holding.
Northern Trust Company of Connecticut first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
124 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.